Aquablation as salvage therapy for benign prostatic hyperplasia: an international multicentre study
Open Access
- 7 October 2026
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 138 (6) , 1171-1179
Abstract
Objective: Our objective was to evaluate the safety and effectiveness of Aquablation® as a salvage therapy in patients who underwent prior intervention for benign prostatic hyperplasia (BPH). Materials and Methods: We retrospectively analysed 1887 consecutive men from the International Collaborative Aquablation Research Urology Society database between 2018 and 2024 who underwent Aquablation at one of four international centres. The cohort was divided into two groups based on the presence or absence of previous BPH intervention. Baseline characteristics, clinical and functional outcomes, and complication rates were compared between the two groups using analysis of variance and Kruskal–Wallis tests. Finally, exploratory sub‐analyses were performed in the salvage therapy group based on the type of prior BPH intervention. Results: Among the study population of 1887 men, 109 (5.8%) patients had undergone prior BPH intervention, and the remaining 1778 (94.2%) patients served as a control cohort. Prostate volumes were similar between both groups (82.3 vs 78.0 mL; P = 0.18). There were no significant differences in perioperative complications, 30‐day readmission rates, surgical retreatment rates, or sexual function outcome scores (all P > 0.05). There were also similar improvements in maximum urinary flow rates, post‐void residuals, International Prostate Symptom Scores, and quality of life scores (all P > 0.05). When comparing outcomes based on the type of prior BPH intervention, there were no differences in terms of operative time, prostate volumes, presence of median lobe, or complication rates. Conclusion: We observed no statistically significant differences in safety or effectiveness for Aquablation as a salvage therapy for recurrent lower urinary tract symptoms after BPH intervention. Aquablation should be offered to men for whom prior procedures have failed and who want to preserve continence and sexual function.Keywords
This publication has 29 references indexed in Scilit:
- WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract SymptomsEuropean Urology Focus, 2026
- Real-World outcomes of aquablation for benign prostatic hyperplasia: a comparative analysis of the international collaborative aquablation research urology society (ICARUS) database, WATER and WATER-II trialsWorld Journal of Urology, 2026
- Membranous urethral length as a predictor for urinary incontinence after holmium enucleation of the prostate for benign prostatic hyperplasiaWorld Journal of Urology, 2026
- Safety and efficacy of aquablation in men 80 years or older: an analysis of the international collaborative aquablation research urology society (ICARUS) real-world databaseWorld Journal of Urology, 2025
- Reintervention rates after minimally invasive benign prostatic hyperplasia therapies: a systematic review including industry involvementWorld Journal of Urology, 2025
- Medical Treatment Incidence and Persistence After Surgical Relief of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: A Critical Analysis of the LiteratureEuropean Urology Focus, 2023
- Bladder neck stenosis after transurethral prostate surgery: a systematic review and meta-analysisWorld Journal of Urology, 2021
- Can we predict the success of prostatic surgery for male lower urinary tract symptoms: ICI‐RS 2018?Neurourology and Urodynamics, 2019
- Outcomes of Holmium Laser Enucleation of the Prostate in the Re-Treatment SettingJournal of Urology, 2017
- Holmium Laser Enucleation of the Prostate: Long-Term Durability of Clinical Outcomes and Complication Rates During 10 Years of FollowupJournal of Urology, 2011